← Back to Search

Dietary Supplement

Fucoidan for Inflammation

N/A
Waitlist Available
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights

Study Summary

This trial aims to see if taking a supplement called fucoidan for 8 weeks can help cancer patients with fatigue after treatment. Researchers will also look at how fatigue, weakness, and inflammation change

Who is the study for?
This trial is for cancer survivors who are experiencing fatigue after their treatment. Participants should be interested in trying a seaweed supplement called fucoidan for 8 weeks to see if it helps reduce their tiredness and inflammation.Check my eligibility
What is being tested?
The study is testing two types of fucoidan supplements, one from U. Pinnatifida seaweed and another from F. Vesiculosus, to evaluate their effectiveness in alleviating post-treatment fatigue and reducing signs of frailty and inflammation in cancer survivors.See study design
What are the potential side effects?
Potential side effects may include digestive discomfort or allergic reactions due to the seaweed origin of the supplements; however, specific side effects related to fucoidan have not been detailed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
percentage of participants who are randomized to the study out of all participants approached
percentage of participants who start the intervention who go on to complete the 8-week or 16-week intervention
percentage of participants who take at least 80% of the fucoidan pills during the study
Secondary outcome measures
mean change in Brief Fatigue Inventory
mean change in C-reactive protein in blood
mean change in D Dimer in blood
+9 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: FucoidanExperimental Treatment1 Intervention
They will receive 4 grams daily of fucoidan extracted from F. Vesiculosus for 8 weeks.
Group II: Usual CareActive Control1 Intervention
They will receive usual care for 8 weeks followed by 4 grams daily of fucoidan extracted from U. Pinnatifida for 8 weeks.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,660 Previous Clinical Trials
40,924,242 Total Patients Enrolled
13 Trials studying Inflammation
3,859 Patients Enrolled for Inflammation
University of RochesterLead Sponsor
838 Previous Clinical Trials
518,537 Total Patients Enrolled
5 Trials studying Inflammation
474 Patients Enrolled for Inflammation

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this medical study currently open for enrollment?

"Per the details on clinicaltrials.gov, this particular research endeavor is no longer in a recruitment phase. It was initially shared on April 15th, 2024 and last revised on February 28th of the same year. Despite its closure to new participants, there are presently 529 alternative trials open for enrollment at present."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer
Jeremy J McGuire 2024. "Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06295588.
~20 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top